During the past decade, Hospital Raja Permaisuri Bainun conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Raja Permaisuri Bainun" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Bayer" with 2 trials sponsored, "BHR Pharma, LLC" with 1 trials sponsored, "Clinical Research Centre, Malaysia" with 1 trials sponsored and "Hospital Raja Permaisuri Bainun" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Raja Permaisuri Bainun" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "M3DICINE Inc." with 1 trials as a collaborator, "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Raja Permaisuri Bainun" are "Generalized Pustular Psoriasis" (3 trials), "Chronic Kidney Disease" (2 trials), "Brain Injuries" (1 trials), "Heart Diseases" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Hospital Raja Permaisuri Bainun" in a lesser frequency.

Most popular intervention types in "Hospital Raja Permaisuri Bainun" are "Drug" (8 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Spesolimab" (3 trials), "Finerenone (BAY94-8862)" (2 trials), "3MTM Littmann® Classic IIITM" (1 trials) and "Airway Ultrasound" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Raja Permaisuri Bainun" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Raja Permaisuri Bainun". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hospital Raja Permaisuri Bainun, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Raja Permaisuri Bainun, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".